Data from an early stage clinical trial suggests Novo Nordisk’s new weight loss pill amycretin could produce greater and more ...

An experimental weight-loss pill helped people drop 13% of their body weight in a three-month period. The results from early ...

A new drug called amycretin is stepping into the spotlight, boasting impressive results that have both researchers and those ...

Shares in Roche dropped to a two-month low on Thursday after an experimental weight-loss pill that carries high market hopes ...

Roche's diversified portfolio and ongoing GLP-1 developments offer decent upside with limited downside. Read more about RHHBY ...